The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hematopoietic Stem Cells (HSCs) Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Hematopoietic Stem Cells (HSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hematopoietic Stem Cells (HSCs) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Blood System Diseases accounting for % of the Hematopoietic Stem Cells (HSCs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Leukocyte segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Hematopoietic Stem Cells (HSCs) include Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, and Cesca Therapeutics Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hematopoietic Stem Cells (HSCs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Market segment by Application, can be divided into
Blood System Diseases
Autoimmune Diseases
Other
Market segment by players, this report covers
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hematopoietic Stem Cells (HSCs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hematopoietic Stem Cells (HSCs), with revenue, gross margin and global market share of Hematopoietic Stem Cells (HSCs) from 2019 to 2022.
Chapter 3, the Hematopoietic Stem Cells (HSCs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hematopoietic Stem Cells (HSCs) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Hematopoietic Stem Cells (HSCs) research findings and conclusion, appendix and data source.
Geographical Area
Global
The Hematopoietic Stem Cells (HSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hematopoietic Stem Cells (HSCs) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Blood System Diseases accounting for % of the Hematopoietic Stem Cells (HSCs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Leukocyte segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Hematopoietic Stem Cells (HSCs) include Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, and Cesca Therapeutics Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hematopoietic Stem Cells (HSCs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Market segment by Application, can be divided into
Blood System Diseases
Autoimmune Diseases
Other
Market segment by players, this report covers
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hematopoietic Stem Cells (HSCs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hematopoietic Stem Cells (HSCs), with revenue, gross margin and global market share of Hematopoietic Stem Cells (HSCs) from 2019 to 2022.
Chapter 3, the Hematopoietic Stem Cells (HSCs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hematopoietic Stem Cells (HSCs) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Hematopoietic Stem Cells (HSCs) research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Hematopoietic Stem Cells (HSCs)
1.2 Classification of Hematopoietic Stem Cells (HSCs) by Type
1.2.1 Overview: Global Hematopoietic Stem Cells (HSCs) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type in 2021
1.2.3 Leukocyte
1.2.4 Lymphocytes
1.2.5 Red Blood Cells
1.2.6 Platelets
1.3 Global Hematopoietic Stem Cells (HSCs) Market by Application
1.3.1 Overview: Global Hematopoietic Stem Cells (HSCs) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Blood System Diseases
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Global Hematopoietic Stem Cells (HSCs) Market Size & Forecast
1.5 Global Hematopoietic Stem Cells (HSCs) Market Size and Forecast by Region
1.5.1 Global Hematopoietic Stem Cells (HSCs) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Hematopoietic Stem Cells (HSCs) Market Size by Region, (2017-2022)
1.5.3 North America Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2017-2028)
1.5.4 Europe Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2017-2028)
1.5.6 South America Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hematopoietic Stem Cells (HSCs) Market Drivers
1.6.2 Hematopoietic Stem Cells (HSCs) Market Restraints
1.6.3 Hematopoietic Stem Cells (HSCs) Trends Analysis
2 Company Profiles
2.1 Kite Pharma Inc.
2.1.1 Kite Pharma Inc. Details
2.1.2 Kite Pharma Inc. Major Business
2.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product and Solutions
2.1.4 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Kite Pharma Inc. Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product and Solutions
2.2.4 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 PromoCell
2.3.1 PromoCell Details
2.3.2 PromoCell Major Business
2.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Product and Solutions
2.3.4 PromoCell Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 PromoCell Recent Developments and Future Plans
2.4 CellGenix Technologie Transfer GmbH
2.4.1 CellGenix Technologie Transfer GmbH Details
2.4.2 CellGenix Technologie Transfer GmbH Major Business
2.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product and Solutions
2.4.4 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 CellGenix Technologie Transfer GmbH Recent Developments and Future Plans
2.5 Cesca Therapeutics Inc.
2.5.1 Cesca Therapeutics Inc. Details
2.5.2 Cesca Therapeutics Inc. Major Business
2.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product and Solutions
2.5.4 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Cesca Therapeutics Inc. Recent Developments and Future Plans
2.6 R&D Systems
2.6.1 R&D Systems Details
2.6.2 R&D Systems Major Business
2.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Product and Solutions
2.6.4 R&D Systems Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 R&D Systems Recent Developments and Future Plans
2.7 Genlantis
2.7.1 Genlantis Details
2.7.2 Genlantis Major Business
2.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Product and Solutions
2.7.4 Genlantis Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Genlantis Recent Developments and Future Plans
2.8 Lonza Group Ltd.
2.8.1 Lonza Group Ltd. Details
2.8.2 Lonza Group Ltd. Major Business
2.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product and Solutions
2.8.4 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Lonza Group Ltd. Recent Developments and Future Plans
2.9 TiGenix N.V.
2.9.1 TiGenix N.V. Details
2.9.2 TiGenix N.V. Major Business
2.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product and Solutions
2.9.4 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 TiGenix N.V. Recent Developments and Future Plans
2.10 ScienCell Research Laboratories
2.10.1 ScienCell Research Laboratories Details
2.10.2 ScienCell Research Laboratories Major Business
2.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product and Solutions
2.10.4 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 ScienCell Research Laboratories Recent Developments and Future Plans
2.11 China Cord Blood Corporation
2.11.1 China Cord Blood Corporation Details
2.11.2 China Cord Blood Corporation Major Business
2.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product and Solutions
2.11.4 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 China Cord Blood Corporation Recent Developments and Future Plans
2.12 Vcanbio
2.12.1 Vcanbio Details
2.12.2 Vcanbio Major Business
2.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Product and Solutions
2.12.4 Vcanbio Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Vcanbio Recent Developments and Future Plans
2.13 Boyalife
2.13.1 Boyalife Details
2.13.2 Boyalife Major Business
2.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Product and Solutions
2.13.4 Boyalife Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Boyalife Recent Developments and Future Plans
2.14 Beike Biotechnology
2.14.1 Beike Biotechnology Details
2.14.2 Beike Biotechnology Major Business
2.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product and Solutions
2.14.4 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Beike Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hematopoietic Stem Cells (HSCs) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Hematopoietic Stem Cells (HSCs) Players Market Share in 2021
3.2.2 Top 10 Hematopoietic Stem Cells (HSCs) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Hematopoietic Stem Cells (HSCs) Players Head Office, Products and Services Provided
3.4 Hematopoietic Stem Cells (HSCs) Mergers & Acquisitions
3.5 Hematopoietic Stem Cells (HSCs) New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hematopoietic Stem Cells (HSCs) Revenue and Market Share by Type (2017-2022)
4.2 Global Hematopoietic Stem Cells (HSCs) Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Application (2017-2022)
5.2 Global Hematopoietic Stem Cells (HSCs) Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2028)
6.2 North America Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2028)
6.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Country
6.3.1 North America Hematopoietic Stem Cells (HSCs) Revenue by Country (2017-2028)
6.3.2 United States Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
6.3.3 Canada Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
6.3.4 Mexico Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2028)
7.2 Europe Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2028)
7.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country
7.3.1 Europe Hematopoietic Stem Cells (HSCs) Revenue by Country (2017-2028)
7.3.2 Germany Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
7.3.3 France Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
7.3.5 Russia Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
7.3.6 Italy Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2028)
8.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2028)
8.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region
8.3.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Region (2017-2028)
8.3.2 China Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
8.3.3 Japan Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
8.3.4 South Korea Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
8.3.5 India Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
8.3.7 Australia Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2028)
9.2 South America Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2028)
9.3 South America Hematopoietic Stem Cells (HSCs) Market Size by Country
9.3.1 South America Hematopoietic Stem Cells (HSCs) Revenue by Country (2017-2028)
9.3.2 Brazil Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
9.3.3 Argentina Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2028)
10.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2028)
10.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country
10.3.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Country (2017-2028)
10.3.2 Turkey Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
10.3.4 UAE Hematopoietic Stem Cells (HSCs) Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Hematopoietic Stem Cells (HSCs) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Hematopoietic Stem Cells (HSCs) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Hematopoietic Stem Cells (HSCs) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Hematopoietic Stem Cells (HSCs) Revenue (USD Million) by Region (2017-2022)
Table 5. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region (2023-2028)
Table 6. Kite Pharma Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Kite Pharma Inc. Major Business
Table 8. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 9. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 13. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. PromoCell Corporate Information, Head Office, and Major Competitors
Table 15. PromoCell Major Business
Table 16. PromoCell Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 17. PromoCell Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. CellGenix Technologie Transfer GmbH Corporate Information, Head Office, and Major Competitors
Table 19. CellGenix Technologie Transfer GmbH Major Business
Table 20. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 21. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Cesca Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Cesca Therapeutics Inc. Major Business
Table 24. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 25. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. R&D Systems Corporate Information, Head Office, and Major Competitors
Table 27. R&D Systems Major Business
Table 28. R&D Systems Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 29. R&D Systems Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Genlantis Corporate Information, Head Office, and Major Competitors
Table 31. Genlantis Major Business
Table 32. Genlantis Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 33. Genlantis Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Lonza Group Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Lonza Group Ltd. Major Business
Table 36. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 37. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. TiGenix N.V. Corporate Information, Head Office, and Major Competitors
Table 39. TiGenix N.V. Major Business
Table 40. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 41. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. ScienCell Research Laboratories Corporate Information, Head Office, and Major Competitors
Table 43. ScienCell Research Laboratories Major Business
Table 44. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 45. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. China Cord Blood Corporation Corporate Information, Head Office, and Major Competitors
Table 47. China Cord Blood Corporation Major Business
Table 48. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 49. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Vcanbio Corporate Information, Head Office, and Major Competitors
Table 51. Vcanbio Major Business
Table 52. Vcanbio Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 53. Vcanbio Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Boyalife Corporate Information, Head Office, and Major Competitors
Table 55. Boyalife Major Business
Table 56. Boyalife Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 57. Boyalife Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Beike Biotechnology Corporate Information, Head Office, and Major Competitors
Table 59. Beike Biotechnology Major Business
Table 60. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product and Solutions
Table 61. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Hematopoietic Stem Cells (HSCs) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Hematopoietic Stem Cells (HSCs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Hematopoietic Stem Cells (HSCs) Players Head Office, Products and Services Provided
Table 66. Hematopoietic Stem Cells (HSCs) Mergers & Acquisitions in the Past Five Years
Table 67. Hematopoietic Stem Cells (HSCs) New Entrants and Expansion Plans
Table 68. Global Hematopoietic Stem Cells (HSCs) Revenue (USD Million) by Type (2017-2022)
Table 69. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Type (2017-2022)
Table 70. Global Hematopoietic Stem Cells (HSCs) Revenue Forecast by Type (2023-2028)
Table 71. Global Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2022)
Table 72. Global Hematopoietic Stem Cells (HSCs) Revenue Forecast by Application (2023-2028)
Table 73. North America Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Hematopoietic Stem Cells (HSCs) Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Hematopoietic Stem Cells (HSCs) Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Hematopoietic Stem Cells (HSCs) Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Hematopoietic Stem Cells (HSCs) Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Hematopoietic Stem Cells (HSCs) Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Hematopoietic Stem Cells (HSCs) Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Hematopoietic Stem Cells (HSCs) Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Hematopoietic Stem Cells (HSCs) Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Hematopoietic Stem Cells (HSCs) Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Hematopoietic Stem Cells (HSCs) Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Hematopoietic Stem Cells (HSCs) Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Hematopoietic Stem Cells (HSCs) Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Hematopoietic Stem Cells (HSCs) Picture
Figure 2. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type in 2021
Figure 3. Leukocyte
Figure 4. Lymphocytes
Figure 5. Red Blood Cells
Figure 6. Platelets
Figure 7. Hematopoietic Stem Cells (HSCs) Revenue Market Share by Application in 2021
Figure 8. Blood System Diseases Picture
Figure 9. Autoimmune Diseases Picture
Figure 10. Other Picture
Figure 11. Global Hematopoietic Stem Cells (HSCs) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Hematopoietic Stem Cells (HSCs) Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region (2017-2028)
Figure 14. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region in 2021
Figure 15. North America Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Hematopoietic Stem Cells (HSCs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Hematopoietic Stem Cells (HSCs) Market Drivers
Figure 21. Hematopoietic Stem Cells (HSCs) Market Restraints
Figure 22. Hematopoietic Stem Cells (HSCs) Market Trends
Figure 23. Kite Pharma Inc. Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. PromoCell Recent Developments and Future Plans
Figure 26. CellGenix Technologie Transfer GmbH Recent Developments and Future Plans
Figure 27. Cesca Therapeutics Inc. Recent Developments and Future Plans
Figure 28. R&D Systems Recent Developments and Future Plans
Figure 29. Genlantis Recent Developments and Future Plans
Figure 30. Lonza Group Ltd. Recent Developments and Future Plans
Figure 31. TiGenix N.V. Recent Developments and Future Plans
Figure 32. ScienCell Research Laboratories Recent Developments and Future Plans
Figure 33. China Cord Blood Corporation Recent Developments and Future Plans
Figure 34. Vcanbio Recent Developments and Future Plans
Figure 35. Boyalife Recent Developments and Future Plans
Figure 36. Beike Biotechnology Recent Developments and Future Plans
Figure 37. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Players in 2021
Figure 38. Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Hematopoietic Stem Cells (HSCs) Revenue Market Share in 2021
Figure 40. Global Top 10 Players Hematopoietic Stem Cells (HSCs) Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Type in 2021
Figure 43. Global Hematopoietic Stem Cells (HSCs) Market Share Forecast by Type (2023-2028)
Figure 44. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Application in 2021
Figure 45. Global Hematopoietic Stem Cells (HSCs) Market Share Forecast by Application (2023-2028)
Figure 46. North America Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2017-2028)
Figure 47. North America Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2017-2028)
Figure 48. North America Hematopoietic Stem Cells (HSCs) Revenue Market Share by Country (2017-2028)
Figure 49. United States Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2017-2028)
Figure 53. Europe Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2017-2028)
Figure 54. Europe Hematopoietic Stem Cells (HSCs) Revenue Market Share by Country (2017-2028)
Figure 55. Germany Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue Market Share by Region (2017-2028)
Figure 63. China Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2017-2028)
Figure 70. South America Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2017-2028)
Figure 71. South America Hematopoietic Stem Cells (HSCs) Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Hematopoietic Stem Cells (HSCs) Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Hematopoietic Stem Cells (HSCs) Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Hematopoietic Stem Cells (HSCs) Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Hematopoietic Stem Cells (HSCs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
